ARTICLE | Clinical News
Haemophilus influenzae type b (Hib) conjugate vaccine: Began Phase I testing
November 1, 1999 8:00 AM UTC
North American Vaccine Inc. (NVX), Columbia, Md. Product: Haemophilus influenzae type b (Hib) conjugate vaccine Business: Infectious diseases Therapeutic category: Viral infection Target: Immune cells...